إعلان
إعلان

ACET

ACET logo

Adicet Bio, Inc. Common Stock

8.02
USD
برعاية
-0.07
-0.82%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

8.05

+0.03
+0.32%

تقارير أرباح ACET

النسبة الإيجابية المفاجئة

ACET تفوق 16 من 32 آخر التقديرات.

50%

التقرير التالي

بيانات التقرير القادم
٠٤ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.19
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
-32.14%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
-40.63%

Adicet Bio, Inc. Common Stock earnings per share and revenue

On ٠٥ نوفمبر ٢٠٢٥, ACET reported earnings of -0.28 USD per share (EPS) for Q3 25, beating the estimate of -0.29 USD, resulting in a 1.86% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.91% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 المحللين forecast an EPS of -0.19 USD, with revenue projected to reach -- USD, implying an نقصان of -32.14% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Adicet Bio, Inc. Common Stock reported EPS of -$0.28, beating estimates by 1.86%, and revenue of $0.00, 0% as expectations.
The stock price moved down -1.91%, changed from $11.04 before the earnings release to $10.83 the day after.
The next earning report is scheduled for ٠٤ مارس ٢٠٢٦.
Based on 9 المحللين, Adicet Bio, Inc. Common Stock is expected to report EPS of -$0.19 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان